Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 17 of 59, showing 10 Applications out of 584 total, starting on record 161, ending on 170

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

161.

ECCT/08/08/02  
    Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples   
Principal Investigator(s)
1. Edwin Onyango Were
Site(s) in Kenya
1. Eldoret Site (Uasin Gishu county)
2. Kisumu Site (Kisumu county)
3. Thika Site (Kiambu county)
4. Nairobi Site (Nairobi City county)
 
25-07-2008 View

162.

ECCT/24/06/04   ALNASA
    A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE       
Principal Investigator(s)
1. Jacqueline Mirera
Site(s) in Kenya
1. Clinical Research Health Network (CREA-N) (Machakos county)
 
23-10-2024 View

163.

ECCT/19/11/04   Second line switch to Dolutegravir (2SD) study
    Switching Treatment-Experienced, Integrase Inhibitor-Naïve, Virally Suppressed HIV-1 Infected Adults from Ritonavir boosted Protease Inhibitors to Dolutegravir: An Open-Label Randomized Controlled Trial               
Principal Investigator(s)
1. Loice Achieng
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
3. Thika Level 5 Hospital (Kiambu county)
4. Kiambu Level 5 Hospital (Kiambu county)
 
23-12-2019 View

164.

ECCT/22/02/02   The Women TAF-FTC Benchmark
    Safety and Pharmacokinetics of TAF-FTC Pre-exposure Prophylaxis in Kenyan Cisgender women   
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD Thika
 
18-11-2022 View

165.

ECCT/15/01/02  
      Study title  An observational pilot study to characterize the immune response  induced by the commercial Varicella Zoster Virus vaccine  Zostavax® (Merck) in healthy adult females in Nairobi, Kenya.  Clinical Phase IV      
Principal Investigator(s)
1. Prof Walter Jaoko Jaoko
Site(s) in Kenya
KAVI-INSTITUTE OF CLINICAL RESEARCH (KAVI-ICR)
 
10-03-2015 View

166.

ECCT/26/06/03   C1091009 - Study Site 1254
    Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants   
Principal Investigator(s)
1. Fredrick Kipyego Sawe
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project (Kericho county)
2. KEMRI Butere Clinical Research Centre (Kakamega county)
3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county)
4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county)
 
08-11-2026 View

167.

ECCT/22/03/08   CVIA 092
    “ A Phase 3 Multicenter, Observer Blind, Randomized, Controlled Study to Evaluate Safety (Ages 6 Months to 45 Years) and Non-inferiority (Ages 9-12 Months) of Multi-dose and Single-dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) against Typbar TCV® and Lot-to-Lot Consistency of the Immune Response (Ages 9-12 Months) to Multi-dose Vial Formulation EuTCV in Healthy African Participants”.    
Principal Investigator(s)
1. Dr Lucy Koech Chepkurui Koech
Site(s) in Kenya
KEMRI/ KERICHO CRC
 
31-05-2022 View

168.

ECCT/25/02/03   NOZE20240219TB
    “Validation of a Digital Olfaction Based Breathalyzer Device for Non-Invasive Detection of Volatile Biomarkers in Patients with and without Tuberculosis: Case Control Study”.   
Principal Investigator(s)
1. Ibrahim Daud
Site(s) in Kenya
KEMRI/WRP CRC Kericho
 
15-05-2025 View

169.

ECCT/18/11/01   PrIMA
              PrEP Implementation for Mothers in Antenatal Care            
Principal Investigator(s)
1. Grace John-Stewart John-Stewart
2. Jared Baeten
Site(s) in Kenya
1. Homa Bay County - 10 sites (Homa Bay county)
2. Siaya County - 10 sites (Siaya county)
 
16-05-2019 View

170.

ECCT/15/06/04   A5316
        A5316           Evaluating Pharmacokinetic Interactions with Vaginal Ring Contraceptives and Antiretroviral Therapy   
Principal Investigator(s)
1. Dr. Esther Mumbi Makanga Makanga
2. Dr. Victor Akelo Akelo
3. Dr.Victor O. Mudhune Mudhune
4. Dr. Kevin P. Cain Cain
Site(s) in Kenya
KEMRI- CDC
 
17-07-2015 View